BUZZ-医疗保险覆盖新型癌症血液检验,NeoGenomics 股价上涨

路透中文
Mar 16
BUZZ-医疗保险覆盖新型癌症血液检验,<a href="https://laohu8.com/S/NEO">NeoGenomics</a> 股价上涨

3月16日 - ** 癌症检测公司NeoGenomics NEO.O股价盘前上涨1.1%至7.97美元

** 该公司称医疗保险现在将支付其PanTracer LBx血液检验费用

** 该检验可查找与癌症有关的基因变化,帮助医生选择治疗方法和进行临床试验

** PanTracer LBx可检测500多种基因,七天内即可出结果 - NEO

** 该公司称,测试在 NeoGenomics 的加利福尼亚实验室进行;该公司在美国和英国都设有实验室。

** 2025 年股价下跌约 29%

(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10